Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma

Br J Haematol. 2018 Jul;182(2):297-301. doi: 10.1111/bjh.14775. Epub 2017 May 23.

Rie S Bech^{1

2}, Kasper L Nielsen³, Thomas S Larsen⁴, Hans H Bentzen⁵, Line S Lynggaard⁵, Trung H Do⁶, Peter Braendstrup⁶, Jessica Brady⁷, N George Mikhaeel⁷, Karen Dybkaer^{2

3}, Hans E Johnsen^{2

8}, Paw Jensen², Martin Bøgsted^{2

3}, Tarec C El-Galaly²

¹ Department of Medicine, Regionshospitalet Nordjylland, Hjørring, Denmark.
² Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.
³ Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
⁴ Department of Haematology, Odense University Hospital, Odense, Denmark.
⁵ Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
⁶ Department of Haematology, Copenhagen University Hospital, Herlev, Denmark.
⁷ Department of Clinical Oncology, Guy's and St Thomas' Hospital, London, England.
⁸ Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.

No abstract available

Keywords: Follicular lymphoma; immunochemotherapy; maintenance therapy; non-Hodgkin lymphoma; rituximab.

Publication types